Cerca
Cerca
+

UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases

default_image

AdnKronos
  • a
  • a
  • a

Dai blog